View Pages
Ted Weisberg: Navigating a Difficult Market — Volatile Picks and Big Pharma Values
Ted Weisberg outlines strategies to exploit volatility—watch ICE, VIRT—and prefers value big-pharma names like Merck, Bristol Myers, and Pfizer over high flyers such as Eli Lilly.
Editorial companion
What stands out
Ted Weisberg returned to the NYSE and called the market "difficult," recommending traders lean into volatility with Intercontinental Exchange (ICE) and Virtu Financial (VIRT) while rotating into big-pharma value names like Merck (MRK), Bristol Myers Squibb (BMY), and Pfizer (PFE) instead of Eli Lilly (LLY). The clip matters because it pairs short-term, tradeable volatility ideas with longer-duration, income-oriented pharma picks, a practical roadmap for investors who want exposure to chop without abandoning balance-sheet stability.
View Pages